Short-squeeze candidates aren’t very hard to come across in this environment. The current macroeconomic environment has ensured there is no scarcity of cash-burning businesses that are barely afloat. Thus, the bearish sentiment behind these companies has caused many stocks to have unusually high short-interest ratios. Such high short-interest ratios can make these stocks well-positioned to
0 Comments
While it might be difficult to believe in a broader economic recovery with all the ugly headwinds, it’s possible that circumstances might improve, thus bolstering transportation stocks to buy. Fundamentally, the economy has proven resilient. In fact. despite the failure of three major regional banks, commercial activity keeps on chugging. In addition, the unemployment rate is
0 Comments
As 2023 unfolds, it brings about several new possibilities in the investment arena, breathing new life into promising growth stocks. After tech stocks were punished in 2022, many of the top tech growth stocks are showing signs of a vibrant comeback. However, sectors previously flourishing, such as energy stocks and regional banks, are now facing
0 Comments
As the saying goes, “nothing ventured, nothing gained.” That’s the trade-off with high-risk stocks. In exchange for the risk of sustaining large losses, investors in risky equities receive the potential for massive gains. During the 2020/2021 runaway bull market, risk-hungry investors crushed it, as speculative growth stocks soared to lofty prices. This was thanks in large
0 Comments
Sharply contrasting with the play-it-safe approach, daring investors might be interested in millionaire-maker tech stocks. With digital innovation accelerating at a rapid clip, the technology ecosystem offers arguably the best chance for market upside. From sectors such as artificial intelligence, advanced energy solutions, and the blockchain, tech has undergirded myriad success stories. To be sure,
0 Comments
If you’re a risk taker on the lookout for stocks with 1000% upside potential, you’d have to venture into speculative territory. It is difficult to find analyst ratings with such a high upside potential unless catalysts could propel the stock that high. Such catalysts include promising drug candidates that are awaiting approval or going through
0 Comments